Three plants are part of the company’s pharmaceutical division, while the fourth plant is part of the medical device division. Johnson & Johnson will invest up to $225 million to expand the facilities, which will make way for more than 300 new jobs.
More Articles on Orthopedic Devices:
Arthritis Foundation to Honor Dr. James Marvel
Zimmer Celebrates 15 Years of Trabecular Metal for Joint Replacements
FOI, Florida Hospital to Launch Clinical Study of Spinal Device
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
